Gut Microbiome Modulation in Hepatocellular Carcinoma: Preventive Role in NAFLD/NASH Progression and Potential Applications in Immunotherapy-Based Strategies

Gut Microbiome Modulation in Hepatocellular Carcinoma: Preventive Role in NAFLD/NASH Progression and Potential Applications in Immunotherapy-Based Strategies

Hepatocellular carcinoma (HCC) is a heterogeneous tumor associated with several risk factors, with non-alcoholic fatty liver disease (NAFLD) emerging as an important cause of liver tumorigenesis. Due to the obesity epidemics, the occurrence of NAFLD has significantly increased with nearly 30% preval...

Full description

Saved in:
Bibliographic Details
Main Authors: Elisa Monti, Clara Vianello, Ilaria Leoni, Giuseppe Galvani, Annalisa Lippolis, Federica D’Amico, Sara Roggiani, Claudio Stefanelli, Silvia Turroni, Francesca Fornari
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Cells
Subjects:
HCC
NAFLD
microbiome
immunotherapy
Online Access:https://www.mdpi.com/2073-4409/14/2/84
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items